Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Thomas, D. P.
space
  arrow  Roberts, H. R.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

UPDATE

Hypercoagulability in Venous and Arterial Thrombosis

right arrow Duncan P. Thomas, MD, and Harold R. Roberts, MD

15 April 1997 | Volume 126 Issue 8 | Pages 638-644

The term "hypercoagulability" is used to describe patients who are at increased risk for thrombosis because of inherited defects in their anticoagulant pathways or because of various predisposing causes. About one in five patients of European descent who present with venous thromboembolism have a specific genetic defect in their anticoagulant pathway. In these patients, anticoagulant prophylaxis is indicated at times of high risk, such as after surgery. Prolonged anticoagulant therapy may be required in patients with recurrent or life-threatening thromboemboli, but decisions about this are best made on an individual basis. Patients who present with arterial thrombosis usually develop their disease as a complication of atherosclerosis. However, these patients also have a form of hypercoagulability, manifested primarily by high fibrinogen levels and elevated factor VII activity. Evidence increasingly indicates that these and other hemostatic markers may help in the assessment of patients at risk for coronary heart disease.

Author and Article Information
space

From University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Grant Support: In part by National Heart, Lung, and Blood Institute grant HL 26309 (Dr. Roberts).
Requests for Reprints: Harold R. Roberts, MD, Division of Hematology/Oncology, Department of Medicine, CB 7035, 932 Faculty Office Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7035.
Current Author Addresses: Drs. Thomas and Roberts: Division of Hematology/Oncology, Department of Medicine, CB 7035, 932 Faculty Office Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7035.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
W. M. Lijfering, H. G. Sprenger, R. R. Georg, P. A. van der Meulen, and J. van der Meer
Relationship between Progression to AIDS and Thrombophilic Abnormalities in HIV Infection
Clin. Chem., July 1, 2008; 54(7): 1226 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
A A Abbasi and N S Harrop
An unusual swelling in the neck
Emerg. Med. J., September 1, 2005; 22(9): 674 - 675.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Layton, E. Heeley, K. Hughes, and S. A. W. Shakir
Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data
Rheumatology, November 1, 2003; 42(11): 1342 - 1353.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. E. Dalen
Pulmonary Embolism: What Have We Learned Since Virchow?: Natural History, Pathophysiology, and Diagnosis
Chest, October 1, 2002; 122(4): 1440 - 1456.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
P. Lochow, A. Schwartzbard, J. Guest, C. Ripps, D. Matalon, R. Gambetta, P. A. Tunick, and S. Sedlis
Elevated Prothrombin and Activated Protein C Resistance in Patients with Thoracic Aortic Atheroma
Angiology, July 1, 2002; 53(4): 423 - 428.
[Abstract] [PDF]


Home page
NEJMHome page
W. C. Aird and E. J. Mark
Case 15-2002 - A 53-Year-Old Man with a Myocardial Infarct and Thromboses after Coronary-Artery Bypass Grafting
N. Engl. J. Med., May 16, 2002; 346(20): 1562 - 1570.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. M. Edelberg, P. D. Christie, and R. D. Rosenberg
Regulation of Vascular Bed-Specific Prothrombotic Potential
Circ. Res., July 20, 2001; 89(2): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. D. Bushnell and L. B. Goldstein
Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke, December 1, 2000; 31(12): 3067 - 3078.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. H. Ellis, Y. Manor, and M. Witz
Risk Factors and Management of Patients With Upper Limb Deep Vein Thrombosis*
Chest, January 1, 2000; 117(1): 43 - 46.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. D. Rosenberg and W. C. Aird
Vascular-Bed-Specific Hemostasis and Hypercoagulable States
N. Engl. J. Med., May 20, 1999; 340(20): 1555 - 1564.
[Full Text] [PDF]


Home page
HeartHome page
I Bux-Gewehr, A Nacke, and G E Feurle
Recurring myocardial infarction in a 35 year old woman
Heart, March 1, 1999; 81(3): 316 - 317.
[Abstract] [Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.